Hepatology

Abnormal liver tests, MASLD, cirrhosis, viral hepatitis, autoimmune and cholestatic liver disease.

← All Clinical Questions

• 70How Can Bowel Preparation Quality Be Improved?
• 189How Is Hepatitis D Treated in 2026?
• 182How Should an HBsAg-Positive Patient With Normal ALT Be Managed?
• 193How Should Autoimmune Hepatitis Be Diagnosed?
• 195How Should Autoimmune Hepatitis Treatment Be Withdrawn?
• 200How Should Cholangiocarcinoma Surveillance Be Performed in Primary Sclerosing Cholangitis?
• 74How Should Chronic Constipation Be Investigated?
• 78How Should FIB-4 Be Used in Clinical Practice?
• 183How Should HBV DNA and ALT Be Interpreted Together?
• 186How Should Hepatitis B Reactivation Risk Be Managed Before Immunosuppression?
• 188How Should Hepatitis D Be Screened for in Patients With Hepatitis B?
• 76How Should Irritable Bowel Syndrome Be Diagnosed Without Excessive Testing?
• 73How Should Microscopic Colitis Be Diagnosed and Treated?
• 191How Should Patients Be Followed After Hepatitis C Cure?
• 196How Should Primary Biliary Cholangitis Be Diagnosed?
• 199How Should Primary Sclerosing Cholangitis Be Diagnosed and Monitored?
• 185Tenofovir or Entecavir: How Should First-Line Hepatitis B Therapy Be Chosen?
• 77What Alarm Features in Lower-GI Symptoms Should Prompt Further Investigation?
• 69What Constitutes an Adequate Bowel Preparation for Colonoscopy?
• 67What Is a Sessile Serrated Lesion and Why Does It Matter?
• 68What Should Be Done After an Incomplete Colonoscopy?
• 184When Can Hepatitis B Antiviral Therapy Be Stopped?
• 72When Does Recurrent Diverticulitis Require Surgical Consultation?
• 197When Is Ursodeoxycholic Acid Inadequate in Primary Biliary Cholangitis?
• 194When Should Autoimmune Hepatitis Be Treated With Steroids and Azathioprine?
• 79When Should Transient Elastography Be Ordered?
• 66Which Colorectal Polyps Carry the Greatest Cancer Risk?
• 75Which Patients With Constipation Require Colonoscopy?
• 71Which Patients With Diverticulitis Need Colonoscopy Afterward?
• 80Which Patients With MASH Are Candidates for Drug Treatment?
• 198Which Second-Line Therapies Should Be Used for Primary Biliary Cholangitis?
• 187Who Needs Hepatitis B Prophylaxis During Chemotherapy or Biologic Therapy?
• 181Who Should Be Treated for Chronic Hepatitis B in 2026?
• 192Who Still Needs HCC Surveillance After HCV Eradication?
• 190Who Still Needs Treatment for Hepatitis C?